Jacobs Levy Equity Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$1M Buy
2021
Q4
$684K Buy
2021
Q3
Sell
2021
Q2
$413K Sell
2021
Q1
$1.5M Buy
2020
Q4
$915K Sell
2020
Q3
$1.71M Buy
2020
Q2
Sell
2020
Q1
$186K Buy
2019
Q3
Sell
2019
Q2
$328K Buy
2018
Q3
Sell
2018
Q2
$142K Buy
2018
Q1
Sell
2017
Q4
$85K Buy